Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer

被引:30
作者
Krecicki, T
Zalesska-Krecicka, M
Jelen, M
Szkudlarek, T
Horobiowska, M
机构
[1] Med Acad Wroclaw, Dept Otolaryngol, Clin Otolaryngol, PL-50368 Wroclaw, Poland
[2] Med Acad Wroclaw, Dept Pathol, PL-50368 Wroclaw, Poland
[3] Wroclaw Univ Technol, Fac Math, Wroclaw, Poland
关键词
collagen IV; collagenase IV; laryngeal cancer; neck metastasis;
D O I
10.1046/j.0307-7772.2001.00503.x
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Laryngeal carcinoma has a lower incidence of neck metastases than other malignant carcinomas of the head and neck region. However, some cases are very aggressive, showing neck metastases even in the early stages. In this study the expression of collagen IV and type IV collagenase (MMP-2) were examined immunohistologically in 50 patients with laryngeal carcinomas, and the results were compared with the incidence of neck metastases and other clinicopathological factors. The correlation between collagen IN expression and the existence of nodal metastases was statistically significant (P < 0.001). There was also significant correlation between collagen IV expression and the histological grading of the tumour. There was a tendency for samples with continuous collagen IV staining to have no matrix metalloproteinase-2 (MMP-2) immunoreactivity. No significant correlation was seen between MMP-2 protein expression and clinicopathological parameters although the correlation between MMP-2 and existence of nodal metastases was statistically borderline (P = 0.07). Multivariate analysis of the clinicopathological factors that may have an influence on the nodal status in laryngeal cancer revealed that, apart from T stage, collagen IV pattern in the basement membrane surrounding nests of carcinoma is an important prognostic factor.
引用
收藏
页码:469 / 472
页数:4
相关论文
共 9 条
[1]   Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma [J].
Charous, SJ ;
Stricklin, GP ;
Nanney, LB ;
Netterville, JL ;
Burkey, BB .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1997, 106 (04) :271-278
[2]  
Hagedorn HG, 1998, ANTICANCER RES, V18, P201
[3]  
HAVENITH MG, 1988, CANCER-AM CANCER SOC, V62, P2207, DOI 10.1002/1097-0142(19881115)62:10<2207::AID-CNCR2820621023>3.0.CO
[4]  
2-L
[5]   EXPRESSION OF MATRIX METALLOPROTEINASE-2 RELATED TO LYMPH-NODE METASTASIS OF ORAL SQUAMOUS-CELL CARCINOMA - A CLINICOPATHOLOGICAL STUDY [J].
KUSUKAWA, J ;
SASAGURI, Y ;
SHIMA, I ;
KAMEYAMA, T ;
MORIMATSU, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 99 (01) :18-23
[6]  
Liabakk NB, 1996, CANCER RES, V56, P190
[7]  
Murakami M, 1992, Nihon Jibiinkoka Gakkai Kaiho, V95, P1773
[8]   Proteolytic patterns of head and neck squamous cell carcinoma [J].
Schmidt, M ;
Polednik, C ;
Hoppe, F .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1999, 256 (07) :346-350
[9]   EXPRESSION OF METALLOPROTEINASES AND THEIR INHIBITORS IN PRIMARY PULMONARY CARCINOMAS [J].
URBANSKI, SJ ;
EDWARDS, DR ;
MAITLAND, A ;
LECO, KJ ;
WATSON, A ;
KOSSAKOWSKA, AE .
BRITISH JOURNAL OF CANCER, 1992, 66 (06) :1188-1194